These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6124330)

  • 41. Role of the renin-angiotensin system in cardiovascular disease.
    Cohn JN
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):341-4. PubMed ID: 20454841
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
    Azizi M
    N Engl J Med; 1999 Mar; 340(12):967; author reply 968-9. PubMed ID: 10094648
    [No Abstract]   [Full Text] [Related]  

  • 45. Blockade of the renin-angiotensin-aldosterone system with combination angiotensin receptor antagonist and ACE inhibitor therapy: observations from Val-HeFT and CALM.
    Chin BS; Lip GY
    J Hum Hypertens; 2001 Feb; 15(2):89-92. PubMed ID: 11317186
    [No Abstract]   [Full Text] [Related]  

  • 46. Cardiovascular regulation during angiotensin converting enzyme inhibition with captopril in diabetes-associated hypertension.
    Beretta-Piccoli C; Ziegler WH; Antonini P; Bernasconi-Zapf M; Kressebuch H; Pianezzi F
    J Hypertens; 1990 Jul; 8(7):671-8. PubMed ID: 2168458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
    Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
    [No Abstract]   [Full Text] [Related]  

  • 48. Diabetes mellitus, the renin-angiotensin system, and angiotensin-converting enzyme inhibition.
    Björck S; Aurell M
    Nephron; 1990; 55 Suppl 1():10-20. PubMed ID: 2189073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN; Campbell BC; Reid JL
    J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism.
    Mantero F; Fallo F; Opocher G; Armanini D; Boscaro M; Scaroni C
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():289s-293s. PubMed ID: 7032817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension.
    Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ
    J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274
    [No Abstract]   [Full Text] [Related]  

  • 55. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
    Reams GP; Bauer JH; Lau A
    J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of nitrendipine on blood pressure, renin-angiotensin system, and kidney function in essential hypertension.
    Glorioso N; Manunta P; Troffa C; Pazzola A; Soro A; Pala F; Melis MG; Madeddu P; Tonolo G
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S142-5. PubMed ID: 2468859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly.
    Moore TJ; Thein-Wai W; Dluhy RG; Dawson-Hughes BF; Hollenberg NK; Williams GH
    J Clin Endocrinol Metab; 1980 Aug; 51(2):215-22. PubMed ID: 6995474
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of captopril on blood pressure and on the renin-angiotensin-aldosterone system in coarctation of the aorta.
    Fallo F; Maragno I; Merola P; Mantero F
    Clin Exp Hypertens A; 1983; 5(3):321-8. PubMed ID: 6340859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans.
    Weir MR; Klassen DK; Hoover N; Douglas FL
    J Clin Pharmacol; 1989 Dec; 29(12):1108-16. PubMed ID: 2693500
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.